# Carcinoembryonic Antigen: Beyond a Gastrointestinal Tumour Marker

**Authors:** Aye Aye Tun, Chiaw Yuan Tan, Kosasih Sumitro, Fakhruddin Salim, Kian Chai Lim, Alice Yong, Vui Heng Chong

PMC · DOI: 10.7759/cureus.103182 · Cureus · 2026-02-07

## TL;DR

This case report shows that elevated CEA levels can indicate medullary thyroid carcinoma, not just gastrointestinal cancers, emphasizing the need for broader evaluation.

## Contribution

The report highlights medullary thyroid carcinoma as a cause of elevated CEA, expanding its clinical relevance beyond GI malignancies.

## Key findings

- Elevated CEA levels can be associated with medullary thyroid carcinoma.
- A negative gastrointestinal evaluation should not rule out other CEA-related cancers.
- Genetic testing confirmed hereditary medullary thyroid carcinoma in the patient.

## Abstract

Carcinoembryonic antigen (CEA) is a widely used, non-specific tumour marker for gastrointestinal (GI) malignancies, particularly colorectal cancer (CRC). However, it can also be elevated in non-GI tumours and benign conditions, which are often overlooked.

A 60-year-old, asymptomatic man was referred for assessment of GI malignancy. During a health screening check, he was found to have a markedly elevated CEA, 121.8 ng/mL (reference range: <5.0 ng/mL). His family history included CRC, breast, and thyroid cancers. GI evaluation, which included a colonoscopy and gastroscopy, identified only a small sigmoid polyp and Helicobacter pylori gastritis. A pan-computed tomography (CT) scan showed a left thyroid nodule. He had fine-needle aspiration biopsies of the thyroid nodule on two occasions, and both were negative for malignancy. Serum calcitonin was markedly elevated. Following a discussion, the patient underwent total thyroidectomy, which confirmed multifocal medullary thyroid carcinoma (MTC). Postoperatively, the serum CEA declined and normalised after four months. Genetic testing revealed a germline RET mutation, establishing hereditary MTC. CEA elevation is commonly evaluated for GI malignancies.

This case report highlights that MTC is also associated with elevated CEA. Therefore, this should be assessed when GI evaluations are negative, to avoid delay in diagnosis.

## Linked entities

- **Genes:** RET (ret proto-oncogene) [NCBI Gene 5979]
- **Proteins:** CEACAM5 (CEA cell adhesion molecule 5), Calca (calcitonin-related polypeptide alpha)
- **Diseases:** colorectal cancer (MONDO:0005575), breast cancer (MONDO:0004989), thyroid cancer (MONDO:0002108), medullary thyroid carcinoma (MONDO:0007958)

## Full-text entities

- **Genes:** CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}, RET (ret proto-oncogene) [NCBI Gene 5979] {aka CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1}
- **Diseases:** malignancy (MESH:D009369), Helicobacter pylori gastritis (MESH:D016481), thyroid nodule (MESH:D016606), MTC (MESH:C536914), CRC (MESH:D015179), breast, and thyroid cancers (MESH:D001943), sigmoid polyp (MESH:D011127), GI malignancies (MESH:D005770)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12972588/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12972588/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12972588/full.md

---
Source: https://tomesphere.com/paper/PMC12972588